.pdf.png/:/rs=h:114,cg:true,m/qt=q:95)
.pdf.png/:/rs=h:104,cg:true,m/qt=q:95)
The Complete Pharmaceutical Ecosystem
Pharma Live Expo would be the first of its kind being organised at the commercial capital of India- Mumbai.
The three days of business extravagance will have more than 300 plus exhibitors and about 700 plus products on display. Mumbai - being the gateway to Indian pharmaceutical industry, the expo will witness 8000+ business delegates from all parts of the globe.
Why should you be a part of pharma live expo 2025?
Growth
Government Support
Opportunities
- India’s pharmaceutical export stood at US$ 16.28 billion in FY20.
- The Indian pharmaceutical sector is expected to grow at a CAGR of 22.4% in the near future, and the medical device market is expected to reach US$ 25 billion by 2025.
- The pharmaceutical sector was valued at US$ 33 billion in 2017.
- The Indian healthcare sector, one of the faste
- India’s pharmaceutical export stood at US$ 16.28 billion in FY20.
- The Indian pharmaceutical sector is expected to grow at a CAGR of 22.4% in the near future, and the medical device market is expected to reach US$ 25 billion by 2025.
- The pharmaceutical sector was valued at US$ 33 billion in 2017.
- The Indian healthcare sector, one of the fastest-growing sectors, is expected to cross US$ 372 billion by 2022.
Opportunities
Government Support
Opportunities
- Due to a genetically diverse population and the availability of skilled doctors, India has the potential to attract huge investments in its clinical trial market.
- With increasing population and income levels, demand for high-end drugs is expected to rise.
- Due to a genetically diverse population and the availability of skilled doctors, India has the potential to attract huge investments in its clinical trial market.
- With increasing population and income levels, demand for high-end drugs is expected to rise.
- Growing demand could open up the market for the production of high-end drugs in India.
- With 70% of India’s population residing in rural areas, pharma companies have immense opportunities to tap this market.
Government Support
Government Support
Government Support
- With 70% of India’s population residing in rural areas, pharma companies have immense opportunities to tap this market.
- The government is planning to relax FDI norms in the pharmaceutical sector.
- The Government of India is planning to set up mega bulk drug parks to reduce the industry's dependency on raw material imports.
- In September 2020,
- With 70% of India’s population residing in rural areas, pharma companies have immense opportunities to tap this market.
- The government is planning to relax FDI norms in the pharmaceutical sector.
- The Government of India is planning to set up mega bulk drug parks to reduce the industry's dependency on raw material imports.
- In September 2020, the government announced a Production Linked Incentive (PLI) scheme for the pharmaceutical industry worth Rs. 15,000 crore (US$ 2.04 billion).
Demand
Government Support
Government Support
- Over US$ 200 billion is expected to be spent on medical infrastructure in the next decade.
- New business models are expected to penetrate tier-2 and tier-3 cities.
- Over 160,000 hospital beds are expected to be added each year in the next decade.
- India’s generic drugs account for 20% of global exports in terms of volume, making the country the largest provider of generic medicines globally.
Contact Us
3-day pharmaceutical exhibition and summit at NESCO, supported by industry associations and the Depa
Message us on WhatsApp
Venue Bombay Exhibition Centre - 17th to 19th Apri
Bombay Exhibition Centre, NESCO, Goregaon, Mumbai, Maharashtra, India
Call +917718843607
